MetLife Investment Management’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $133K | Buy |
|
|||||
|
2025
Q4 | $155K | Sell |
|
|||||
|
2025
Q3 | $281K | Hold |
|
|||||
|
2025
Q2 | $434K | Hold |
|
|||||
|
2025
Q1 | $208K | Buy |
|
|||||
|
2024
Q4 | $141K | Buy |
|
|||||
|
2024
Q3 | $66.1K | Buy |
|
|||||
|
2024
Q2 | $35.5K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $37K | Sell |
|
|||||
|
2021
Q2 | $186K | Buy |
|
|||||
|
2021
Q1 | $73.4K | Buy |
|